Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.86 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HRH2 | P25021 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150332 | 0.98 | MAPT (0.83) | MAPTPOLBALDH1A1PKMHRH3 | |
| SCHEMBL154378 | 0.98 | MAPT (0.83) | MAPTPOLBALDH1A1PKMHRH3 | |
| SCHEMBL27895291 | 0.95 | — | — | |
| SCHEMBL149979 | 0.93 | MAPT (1.00) | MAPTPOLBALDH1A1PKMHRH3 | |
| SCHEMBL151720 | 0.91 | MAPT (0.95) | MAPTPOLBALDH1A1PKMHRH3 | |
| SCHEMBL7224479 | 0.91 | MAPT (0.95) | MAPTPOLBALDH1A1PKMHRH3 | |
| SCHEMBL151103 | 0.91 | MAPT (0.95) | MAPTPOLBALDH1A1PKMHRH3 | |
| SCHEMBL9206204 | 0.91 | MAPT (0.95) | MAPTPOLBALDH1A1PKMHRH3 | |
| SCHEMBL5672438 | 0.90 | — | — | |
| SCHEMBL10498707 | 0.90 | ALDH1A1 (0.70) | MAPTPOLBALDH1A1PKMHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| EP-1132127-B1 | Isolated ultrafine particles | TECLE BERHAN (US) | 2008-12-24 | — | — | EP | claimed |
| US-20060049102-A1 | Ionic polymer membranes | BP CORPORATION NORTH AMERICA INC. | 2006-03-09 | — | — | US | claimed |
| US-6372077-B1 | COATING A FIBER WITH A POWDER ENCAPSULANT MATERIAL IN A HIGHLY DISPERSED COLLOIDAL SUSPENSION SUCH THAT THE ENCAPSULATED PARTICLES REMAIN INDEPENDENT AND DISCRETE UPON SEPARATION | TECLE BERHAN (US) | 2002-04-16 | — | — | US | claimed |
| EP-0917501-B1 | METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES | TECLE BERHAN (US) | 2001-09-19 | — | — | EP | claimed |
| EP-1132127-A2 | Method for isolating ultrafine and fine particles and resulting particles | Tecle, Berhan (US) | 2001-09-12 | — | — | EP | claimed |
| US-6190731-B1 | FORMING A HIGHLY DISPERSED COLLOIDAL SUSPENSION OF PARTICLES, ADDING TO THE SUSPENSION AN ENCAPSULANT MATERIAL TO ENCAPSULATE INDIVIDUAL PARTICLES, AND ISOLATING FROM SAID SUSPENSION INDEPENDENT ENCAPSULATED PARTICLES | Tecle, Berhan | 2001-02-20 | — | — | US | claimed |
| US-5922403-A | ADDING ENCAPSULANT TO HIGHLY DISPERSED COLLOIDAL SUSPENSION OF SOLID PARTICLES TO ENCAPSULATE INDIVIDUAL PARTICLES; AGGLOMERATING; ISOLATING ENCAPSULATED PARTICLES BY SEPARATION FROM SOLVENT LAYER | TECLE, BERHAN | 1999-07-13 | — | — | US | claimed |
| EP-0917501-A1 | METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES | Tecle, Berhan (US) | 1999-05-26 | — | — | EP | claimed |
| WO-1997033713-A1 | METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES | TECLE BERHAN (US) | 1997-09-18 | — | — | WO | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | disclosed |
| US-20230183177-A1 | ENANTIOSELECTIVE CHEMO-ENZYMATIC SYNTHESIS OF OPTICALLY ACTIVE AMINO AMIDE COMPOUNDS | PHARMAZELL GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| EP-4139468-A1 | ENANTIOSELECTIVE CHEMO-ENZYMATIC SYNTHESIS OF OPTICALLY ACTIVE AMINO AMIDE COMPOUNDS | Pharmazell GmbH (DE) | 2023-03-01 | — | — | EP | disclosed |
| CN-114678592-B | Non-aqueous electrolyte containing cyano cyclic amine compound, lithium ion battery and application thereof | 深圳澳睿新能源科技有限公司 | 2022-09-13 | — | — | CN | disclosed |
| US-9709907-B2 | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-07-18 | — | — | US | disclosed |
| US-5411995-A | Free radically curable formulations employing dithiolate catalysts | LOCTITE CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
| EP-0490769-B1 | Aminoalkylketone derivatives, process for their preparation and their therapeutical use | LAFON LABOR (FR) | 1995-04-19 | — | — | EP | disclosed |
| US-5217760-A | Of a dithiolate and an organic halogen compound and/or tertiary amine coinitiator | LOCTITE CORPORATION (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0490769-A1 | Aminoalkylketone derivatives, process for their preparation and their therapeutical use | LABORATOIRE L. LAFON (FR) | 1992-06-17 | — | — | EP | disclosed |
| EP-0467649-A2 | Free radically curable formulations employing dithiolate catalysts | LOCTITE CORPORATION (US) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183177-A1 | ENANTIOSELECTIVE CHEMO-ENZYMATIC SYNTHESIS OF OPTICALLY ACTIVE AMINO AMIDE COMPOUNDS | COASY, NAAA, HNMT | MAPT 3930/4885POLB 246/4885ALDH1A1 444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.